Proteomics International Laboratories Ltd Stock Market Press Releases and Company Profile
Proteomics International Webinar and Q&A
Proteomics International Webinar and Q&A

Perth, Sep 29, 2023 AEST (ABN Newswire) - Proteomics International Laboratories Ltd (googlechartASX:PIQ) is pleased to invite shareholders, investors and interested parties to an online update on the recent announcement regarding the PromarkerD US Reimbursement Price and the Australian Regulatory Decision, hosted by MD, Dr Richard Lipscombe.

The webinar will be held on Tuesday 3rd October 2023 at 12:00pm AEDT / 11:00am AEST / 9:00am AWST For the Q&A session, investors are invited to send questions for the webinar prior to 5:00pm AEDT Monday 2nd October 2023 to:

Register for the webinar at the link below:

After registering, you will receive a confirmation email containing information about joining the webinar. A recording will be available at the above link shortly after the conclusion of the live session.

About Proteomics International Laboratories Ltd

Proteomics International Laboratories LtdProteomics International Laboratories (ASX:PIQ) is a wholly owned subsidiary and trading name of PILL, a medical technology company at the forefront of predictive diagnostics and bioanalytical services. The Company specialises in the area of proteomics - the industrial scale study of the structure and function of proteins. Proteomics International's mission is to improve the quality of lives by the creation and application of innovative tools that enable the improved treatment of disease. 


Dr Richard Lipscombe
Managing Director
Proteomics International Laboratories Ltd
T: +61 8 9389 1992

Dirk van Dissel
Investor Relations & Corporate Advisor
Candour Advisory
T: +61 408 326 367

Kyle Moss
Corporate Advisor
Euroz Hartleys
T: +61 8 9488 1400

ABN Newswire
ABN Newswire This Page Viewed:  (Last 7 Days: 25) (Last 30 Days: 242) (Since Published: 2143)